New disease-modifying anti-rheumatic drugs (DMARDs) for rheumatoid arthritis are usually expensive and insurers, including Medicare, will often limit access. This study examined Medicare Advantage and ...

KT501 is engineered to target a broad spectrum of B-cell populations, including plasma cells, by simultaneously binding to CD19 and BCMA. Unlike traditional B-cell therapies, KT501 is designed to ...

Patients in East Central Indiana facing complex medical conditions like Alzheimer’s, Crohn’s disease, and multiple sclerosis no longer have to travel long distances for specialized care. Hancock ...

Patients in East Central Indiana facing complex medical conditions like Alzheimer’s, Crohn’s disease, and multiple sclerosis no longer have to travel long distances for specialized care.

Current treatments focus on controlling inflammation and minimizing long-term damage. Learn more.

Artiva Biotherapeutics (NASDAQ:ARTV) used a presentation and fireside chat at TD Cowen’s 46th Annual Healthcare Conference to outline its strategy in “deep B-cell depletion” for autoimmune disease, em ...

Dr. Tom Walsh, DVM, CCAT, CCRP, MBA, had a successful career in telecommunications but always knew his true calling was helping animals. Deciding to pursue that passion, he became a veterinarian and ...

Renée Fabian is Lead Editor for Pet Health at Forbes Advisor. She has over 10 years experience as a journalist and editor covering pet and human health topics ...

Please provide your email address to receive an email when new articles are posted on . The open-label RESET-RA trial offers real-world data for vagus nerve stimulation. Vagus nerve stimulation ...

Rheumatoid arthritis (RA) is a common autoimmune disease where the body's immune system mistakenly attacks the lining of its own joints, causing chronic pain, swelling, and stiffness. While there have ...

As of 2021, about 17.9 million people around the world were living with rheumatoid arthritis, an autoimmune disease causing inflammation, pain, and swelling in the joints. There is also currently no ...